Antiviral Drugs Market to Clock US$82.9 bn by 2024, Rise in Number of FDA approval to Fuel Market’s Growth

Antiviral Drugs Market Segmentation by Disease
Indication - Hepatitis Virus Infection, HIV Infection,
and Respiratory Virus Infection; Product Type -
Branded Drugs and Generic Drugs; Distribution
Channels - Hospital Pharmacy Store, Retail Pharmacy
Store, and Online Pharmacy, and Forecast, 2016 - 2024
©2019 Transparency Market Research, All Rights Reserved

Sr. No.
Chapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Chapter 8
Chapter 9
Chapter 10
Chapter 11
Chapter 12
Chapter 13
Chapter 14
Content
Preface
Assumptions and Research Methodology
Market Overview
Market Dynamics
Global Antiviral Drugs Market Analysis and Forecasts, By Software Type
Global Antiviral Drugs Market Analysis, by Modality
Global Antiviral Drugs Market Analysis, by Application
Global Antiviral Drugs Market Analysis, by End-user
Global Antiviral Drugs Market Analysis and Forecast by Region
Europe Antiviral Drugs Market Analysis and Forecast
Asia Pacific Antiviral Drugs Market Analysis and Forecast
Latin America Antiviral Drugs Market Analysis and Forecast
Middle East & Africa Antiviral Drugs Market Analysis and Forecast
Competition Landscape
©2019 Transparency Market Research, All Rights Reserved

Antiviral drugs refer to those prescription medicines that are capable of fighting against
flu viruses in one’s body.
Antiviral drugs could include intravenous solutions, an inhaled powder, liquid, or pills.
The global antiviral drugs market is likely to observe considerable growth due to the
rising incidences of viral infections.
As coronavirus spreads at an exponential rate and the number of deaths crosses 74,000
worldwide, efforts are being made to lessen transmission through standard public health
interventions. These interventions are based on tracing of contacts and isolation of cases.
So far, there is no drug or vaccine to contain the spread of the pandemic worldwide.
©2019 Transparency Market Research, All Rights Reserved

The global antiviral drugs market will exhibit a healthy CAGR of 6.40% during
the forecast period of 2016 to 2024.
The global antiviral drugs market is projected to rise at a significant pace in the
coming few years.
Availability of strong product pipeline is another factor expected to propel the
growth of the global antiviral drugs market in the coming years.
As per a study, over 36 million people around the globe are suffering from HIV
infection in 2014. Further, the population in the region touched 2.0 million new
cases of HIV.
©2019 Transparency Market Research, All Rights Reserved

Researchers and doctors have observed that antiviral drugs administered shortly
after the onset of symptoms can diminish the infectiousness to others through
diminished viral shredding in the patient’s respiratory secretions.
Growing prevalence of viral diseases such as malaria, dengue, chikungunya, and
other deadly viral diseases is prompting an ever increasing demand for these
antiviral drugs from these regions.
Some of the key players in the global antiviral drugs market include names such as
Merck & Co. Inc., Johnson and Johnson, Schering-Plough Corporation, AbbVie
Inc., and AstraZeneca Plc. among others.
©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website
www.transparencymarketresearch.com
For sales queries or new topics email us on:
sales@transparencymarketresearch.com
Thank You
©2019 Transparency Market Research, All Rights Reserved